Predictors of Incident Heart Failure in Patients With Chronic Chagas Disease Cardiomyopathy

Danton Machado da Cunha1, Mauro Felippe Felix Mediano2, Lorena Dos Santos Marreto Rimolo1

  • 1Antonio Pedro University Hospital, Fluminense Federal University, Niterói, RJ, Brazil.

Insights

Echocardiographic measures, including left ventricular ejection fraction and strain parameters, predict heart failure in chronic Chagas cardiomyopathy patients. Diabetes mellitus also indicates increased risk.

Area of Science:

  • Cardiology
  • Echocardiography
  • Chagas disease

Background:

  • Chronic Chagas cardiomyopathy (CCC) is a significant cause of heart failure (HF) and mortality.
  • Early identification of patients at risk for HF is crucial for timely intervention.

Purpose of the Study:

  • To identify clinical and echocardiographic predictors of incident heart failure in patients with early-stage chronic Chagas cardiomyopathy.

Main Methods:

  • A retrospective longitudinal observational study included 176 adult patients with early CCC.
  • Competing-risk survival regression models (Fine and Gray method) were used to analyze associations with incident HF.

Main Results:

  • Diabetes mellitus, lower left ventricular ejection fraction, and reduced E' velocity were associated with increased HF risk.
  • LV global circumferential strain and left atrial booster contraction strain also predicted incident HF.

Conclusions:

  • Echocardiographic parameters, particularly LV systolic and diastolic function and strain measurements, are key predictors of HF in CCC.
  • These findings aid in risk stratification and management planning for CCC patients.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Imbalances in Cardiac Output01:23

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
416
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
316
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
18